Distinguished Cardiovascular Seminar Series Dec. 17
Burns Blaxall, PhD, professor of pediatrics and director of translational science at the Heart Institute, Cincinnati Childrens Hospital Medical Center, will present, "Finding new targets and therapeutics for heart failure," Monday, Dec. 17, at noon in MSB 3351.
Blaxall will be available to meet with graduate students immediately after the seminar in Room 1919 of the Cardiovascular Research Center (CVC).
All College of Medicine graduate students are invited.
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.